Deval Lashkari Ph.D

Deval Lashkari Ph.D General Information

Biography

Dr. Deval Lashkari is a Co-Founder & serves as Senior Partner at Telegraph Hill Partners. He serves as Board Member at Mosaic Biosciences. He serves as a Board Member at Excellos, Panome Bio, and Cell Microsystems at Nimble Therapeutics. He served as Board Member at Agena Bioscience. He has over 25 years of experience in various senior management positions in the life science industry, developing and commercializing novel technologies. Prior to Telegraph Hill Partners (THP), he gained corporate and business development experience through management positions at Incyte, Synteni, Operon Technologies, and Genometrix. At THP, he focuses on life science and diagnostics investments. He has represented THP on the boards of AcroMetrix, Active Motif, Althea Technologies, , Applied Precision, Aurora Discovery, and NEXUS Biosystems to name a few. He received a BA from the University of California, Berkeley and a Ph.D. from Stanford University. He served as Board Member at Precision Nanosystems & Argonaut Manufacturing Services. He served as a Board Member at AltheaDx, RareCyte, Aquaro Histology. He is also a Board Member of n6 Tec. Deval is a co-founder of Telegraph Hill Partners and has worked in the life sciences area developing and commercializing novel technologies for over 25 years. Deval has represented THP on the boards of Agena Bioscience, Akoya Biosciences, Applied Precision and Precision NanoSystems amongst many other companies.